New challenges in coronary stenting.
Coronary stenting with the Palmaz-Schatz coronary stent has evolved into an exciting discipline which has undergone radical change through the years. Custom length stents which are heparin-coated and more radiopaque promise to enhance both the safety and efficacy of the procedure in the future. It is hopeful that with elimination of subacute stent thrombosis, vascular bleeding, and lower restenosis rates with the heparin coating, the Palmaz-Schatz coronary stent will be the most cost-effective therapy in the majority of patients with disease of both native coronary arteries and saphenous vein bypass grafts.